Prevalence and Characteristics of Prediabetes and Metabolic Syndrome in Seemingly Healthy Persons at a Health Check-Up Clinic

References

• Hostalek U. Global epidemiology of prediabetes - present and future perspectives. Clin Diabetes Endocrinol. 2019;5:5. doi:10.1186/s40842-019-0080-0
   PubMedGoogle Scholar
• Brannick B, Dagogo-Jack S. Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction. Endocrinol Metab Clin North Am. 2018;47(1):33–50. doi:10.1016/j.ecl.2017.10.001
   PubMed Web of Science ®Google Scholar
• Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297–m2297. doi:10.1136/bmj.m2297
   PubMed Web of Science ®Google Scholar
• Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953–i5953. doi:10.1136/bmj.i5953
   PubMed Web of Science ®Google Scholar
• Mai L, Wen W, Qiu M, et al. Association between prediabetes and adverse outcomes in heart failure. Diabetes Obes Metab. 2021;23(11):2476–2483. doi:10.1111/dom.14490
   PubMed Web of Science ®Google Scholar
• Cai X, Liu X, Sun L, et al. Prediabetes and the risk of heart failure: a meta-analysis. Diabetes Obes Metab. 2021;23(8):1746–1753. doi:10.1111/dom.14388
   PubMed Web of Science ®Google Scholar
• Al-Rifai RH, Majeed M, Qambar MA, Ibrahim A, AlYammahi KM, Aziz F. Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000–2018. Syst Rev. 2019;8(1):268. doi:10.1186/s13643-019-1187-1
   PubMed Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596
   PubMed Web of Science ®Google Scholar
• Aekplakorn W, Stolk RP, Neal B, et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care. 2003;26(10):2758–2763. doi:10.2337/diacare.26.10.2758
   PubMed Web of Science ®Google Scholar
• Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371(9628):1927–1935. doi:10.1016/s0140-6736(08)60602-9
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–359. doi:10.1001/jama.287.3.356
   PubMed Web of Science ®Google Scholar
• Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care. 2011;34(6):1323–1328. doi:10.2337/dc10-2109
   PubMed Web of Science ®Google Scholar
• Siu SC, Wong KW, Lee KF, et al. Prevalence of undiagnosed diabetes mellitus and cardiovascular risk factors in Hong Kong professional drivers. Diabetes Res Clin Pract. 2012;96(1):60–67. doi:10.1016/j.diabres.2011.12.002
   PubMed Web of Science ®Google Scholar
• Ko G, Tang J. Metabolic syndrome in the Hong Kong community: the United Christian Nethersole Community Health Service primary healthcare programme 2001–2002. Singapore Med J. 2008;48:1111–1116.
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/circulationaha.109.192644
   PubMed Web of Science ®Google Scholar
• Diamantopoulos EJ, Andreadis EA, Tsourous GI, et al. Metabolic syndrome and prediabetes identify overlapping but not identical populations. Exp Clin Endocrinol Diabetes. 2006;114(7):377–383. doi:10.1055/s-2006-924319
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–s31. doi:10.2337/dc20-S002
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30(1):8–13. doi:10.2337/dc06-1414
   PubMed Web of Science ®Google Scholar
• Hu H, Nakagawa T, Honda T, et al. Low serum creatinine and risk of diabetes: the Japan epidemiology collaboration on occupational health study. J Diabetes Investig. 2019;10(5):1209–1214. doi:10.1111/jdi.13024
   PubMed Web of Science ®Google Scholar
• Telles S, Pal S, Sharma SK, Singh A, Kala N, Balkrishna A. The association between the lipid profile and fasting blood glucose with weight related outcomes in healthy obese adults. BMC Res Notes. 2018;11(1):383. doi:10.1186/s13104-018-3485-4
   PubMedGoogle Scholar
• Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine. 2013;43(3):504–513. doi:10.1007/s12020-012-9830-9
   PubMed Web of Science ®Google Scholar
• Drew BG, Duffy SJ, Formosa MF, et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009;119(15):2103–2111. doi:10.1161/circulationaha.108.843219
   PubMed Web of Science ®Google Scholar
• Heianza Y, Arase Y, Fujihara K, et al. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA (1c) and impaired fasting glucose: the Toranomon hospital health management center study 4 (TOPICS 4). Diabet Med. 2012;29(9):e279–285. doi:10.1111/j.1464-5491.2012.03686.x
   PubMed Web of Science ®Google Scholar
• Ghachem A, Brochu M, Dionne IJ. Differential clusters of modifiable risk factors for impaired fasting glucose versus impaired glucose tolerance in adults 50 years of age and older. Ther Adv Chronic Dis. 2019;10:2040622319854239. doi:10.1177/2040622319854239
   Web of Science ®Google Scholar
• Sofer Y, Nash Y, Osher E, et al. Insulin-degrading enzyme higher in subjects with metabolic syndrome. Endocrine. 2021;71:357–364. doi:10.1007/s12020-020-02548-2
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang P, Li Z, et al. The prevalence of pre-diabetes and diabetes and their associated factors in Northeast China: a cross-sectional study. Sci Rep. 2019;9(1):2513. doi:10.1038/s41598-019-39221-2
   PubMed Web of Science ®Google Scholar
• CDC. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2020.
   Google Scholar
• Jin JL, Cao YX, Zhang HW, et al. Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and prediabetes or diabetes. Diabetes Care. 2019;42(7):1312–1318. doi:10.2337/dc19-0274
   PubMed Web of Science ®Google Scholar
• Barter PJ. The causes and consequences of low levels of high density lipoproteins in patients with diabetes. Diabetes Metab J. 2011;35(2):101–106. doi:10.4093/dmj.2011.35.2.101
   PubMedGoogle Scholar
• Fryirs MA, Barter PJ, Appavoo M, et al. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol. 2010;30(8):1642–1648. doi:10.1161/atvbaha.110.207373
   PubMed Web of Science ®Google Scholar
• Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–759. doi:10.2337/dc07-9920
   PubMed Web of Science ®Google Scholar
• Oh M-R, Jung S-J, Bae E-J, Park B-H, Chae S-W. Clinical characteristics and associated risk factors of prediabetes in the Southwestern Region of Korea from 2010–2019. J Clin Med. 2020;9(4):1114. doi:10.3390/jcm9041114
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–1139. doi:10.2337/dc05-2179
   PubMed Web of Science ®Google Scholar
• Vesa CM, Behl T, Nemeth S, et al. Prediction of NAFLD occurrence in prediabetes patients. Exp Ther Med. 2020;20(6):190. doi:10.3892/etm.2020.9320
   PubMed Web of Science ®Google Scholar
• Cai X, Zheng S, Liu Y, Zhang Y, Lu J, Huang Y. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation. Liver Int. 2020;40(7):1594–1600. doi:10.1111/liv.14461
   PubMed Web of Science ®Google Scholar
• Cai X, Sun L, Liu X, et al. Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease. Ther Adv Chronic Dis. 2021;12:20406223211024361. doi:10.1177/20406223211024361
   Web of Science ®Google Scholar